Eden GLP-1 Cost vs PlexusDx (2026): Compounded Pricing & Annual Math | PlexusDx

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on GLP-1 therapies, weight management protocols, and the genetic variables that shape every metabolic decision. Browse all Peptides & GLP-1 education

Eden does something most telehealth GLP-1 providers won't: it publishes a flat, dose-independent price for compounded semaglutide and tirzepatide on a public treatment page. Compounded semaglutide runs $129 first month then $249/mo on the 3-month prepaid plan, or $149 first month then $229/mo month-to-month. Compounded tirzepatide runs $249 first month then $329/mo. Brand-name Wegovy is listed at $1,695/mo and brand-name Ozempic, Mounjaro, and Zepbound at $1,399/mo. Those numbers let a cash-pay shopper actually compare. They also raise an obvious question: how does Eden's compounded pricing stack against the PlexusDx Weight Management Protocol lineup — Microdose GLP-1 Protocol at $129/mo flat, Semaglutide Injection at $149/mo, Tirzepatide Injection at $249/mo, Semaglutide Oral from $249/mo, Tirzepatide Oral at $279/mo, and GLP-Squared dual-compound at $249/mo — once you do the annualized math?

Eden GLP-1 cost — what the live treatment page says

Per Eden's GLP-1 treatment page (verified April 2026 by Weight Loss Providers Guide), Eden's cash-pay structure is built on compounded semaglutide and tirzepatide with a separate brand-name path. Compounded semaglutide is $149 first month then $229/mo on the monthly plan, or $129 first month then $249/mo on the 3-month prepaid plan. Compounded tirzepatide is $249 first month then $329/mo. Brand-name Wegovy is $1,695/mo. Brand-name Ozempic, Mounjaro, and Zepbound are $1,399/mo. There is no membership fee, no separate consultation charge, and shipping is included. Eden's distinguishing pricing claim is “Same Price at Every Dose” — your monthly bill on the compounded plans does not change as the provider titrates the dose upward. Eden states it works with pharmacies licensed in all 50 states and is cash-pay only. PlexusDx is also cash-pay with no membership and no insurance billing — the structural pricing models are directly comparable.

PlexusDx pricing — the full lineup at $129-$369/mo

PlexusDx Weight Management Protocols span six prescription compounds across four mechanism classes, all-inclusive of async provider consultation, prescription, compounded medication, and shipping. Microdose GLP-1 Protocol is $129/mo flat — a compounded GLP-1 in capsule, troche, lozenge, or sublingual form, provider-selected. Semaglutide Oral starts at $249/mo, a compounded oral GLP-1 receptor agonist with six dose levels. Semaglutide Injection is $149/mo, a compounded weekly injection across five dose levels from 0.25mg to 2.0mg. Tirzepatide Injection is $249/mo, a compounded GIP/GLP-1 dual-agonist weekly injection across six dose levels. Tirzepatide Oral is $279/mo across seven dose levels. GLP-Squared is $249/mo, a provider-titrated dual-compound therapy stacking semaglutide with tirzepatide. PlexusDx ships to all 50 states; five states require a scheduled live consultation. Any protocol can be paired with the Precision Peptide Genetic Test for $99 after the first month so dosing decisions are anchored to the patient's GIPR, GLP1R, FTO, MC4R, and TCF7L2 variants rather than a population-average titration.

Annualized cost — Eden vs PlexusDx on compounded semaglutide and tirzepatide

Compounded semaglutide is the apples-to-apples line. Eden's 3-month prepaid plan annualizes to $2,428/year ($129 + $209 × 11). Eden's monthly plan annualizes to $2,668/year ($149 + $229 × 11). PlexusDx Semaglutide Injection annualizes to $2,148–$2,748/year depending on dose tier ($149/mo × 12). At the entry tier of $179/mo, PlexusDx is roughly $280/year below Eden's prepaid plan and $520/year below Eden's monthly plan; at the maintenance tier of $229/mo the two are within rounding error. For compounded tirzepatide the gap widens. Eden's compounded tirzepatide annualizes to $3,868/year ($249 + $329 × 11). PlexusDx Tirzepatide Injection annualizes to $2,748–$3,708/year across six dose levels — below Eden at every tier, with $160–$1,120/year of savings depending on where the clinician titrates. PlexusDx GLP-Squared at $249/mo annualizes to $2,148–$3,900/year — competitive with or below Eden's tirzepatide pricing across most of its range while delivering both semaglutide and tirzepatide in a clinician-titrated stack.

The cheap-end and high-end — where PlexusDx covers what Eden doesn't

Eden's lowest published compounded price is $129 first month then $249/mo, locked behind a 3-month prepaid commitment. PlexusDx Microdose GLP-1 Protocol is $129/mo flat with no first-month asterisk and no prepaid commitment — an annualized $1,548/year, roughly $880/year below Eden's cheapest path. The Microdose protocol uses a compounded GLP-1 in four needle-free formats (capsule, troche, lozenge, sublingual). On the other end, PlexusDx Tirzepatide Oral at $279/mo and Semaglutide Oral from $249/mo cover the oral-tirzepatide and oral-semaglutide categories that Eden's published pricing does not include. The four-format Microdose option, oral-tirzepatide protocol, and GLP-Squared stacked dual-compound are three categories where Eden's published treatment page has no equivalent SKU at any price.

The brand-name catch — why Eden's $1,399–$1,695/mo line is the wrong line

Eden's published brand-name prices — $1,695/mo for Wegovy and $1,399/mo for Ozempic, Mounjaro, and Zepbound — are well above what's available through manufacturer self-pay programs as of April 2026. Lilly Direct lists Zepbound self-pay vials starting at $299/mo for the 2.5mg dose and $499/mo for the 7.5mg and higher doses. NovoCare lists Wegovy self-pay at roughly $349–$499/mo after an introductory window. If you specifically want the FDA-approved branded finished drug, the manufacturer self-pay programs are the cheaper route, not Eden's brand-name line. This is also the line where PlexusDx is explicitly not the answer: PlexusDx's lineup is compounded semaglutide and tirzepatide only. Compounded semaglutide and tirzepatide are not FDA-approved finished drug products — they are pharmacy-prepared versions of the same active ingredients, dispensed by licensed U.S. compounding pharmacies. If your insurance covers Wegovy or Zepbound at a low copay, branded through a covered pharmacy is cheaper than any compounded route. If you're cash-pay with no GLP-1 coverage, the compounded route is the cost-effective path and the comparison above is what matters.

Genetic baseline — the variable Eden's pricing structure does not include

GLP-1 response varies meaningfully across patients. Variants in GIPR (the GIP receptor that drives the tirzepatide-specific component), GLP1R, FTO, MC4R, and TCF7L2 are associated with measurably different response patterns to semaglutide and tirzepatide. The Precision Peptide Genetic Test covers 48 unique genes, 57 genetic variants, and 14 health pathways — including 34 weight-management insights and the GIPR rs1800437 variant linked to differential GLP-1 response. It's available standalone for $298 or as a $99 add-on after your first month on any PlexusDx Weight Management Protocol. Eden's pricing structure is genuinely simple, but it does not include any pre-titration genetic stratification. The dose-escalation schedule on every Eden plan starts from a population average and adjusts on subjective tolerability over the first 8–12 weeks. PlexusDx anchors that same conversation to a measurable genetic baseline before week one for an additional $99.

Which one fits — a four-question decision frame

Question 1: Are you cash-pay, prioritizing the lowest possible monthly cost, and willing to use an oral microdose format rather than a weekly injection? Microdose GLP-1 Protocol at $129/mo flat is the cheapest cash-pay GLP-1 path in this comparison. Question 2: Do you want compounded semaglutide injection at the lowest dose tier? PlexusDx Semaglutide Injection at $179/mo entry is roughly $280–$520/year below Eden's compounded semaglutide annualized totals. Question 3: Do you want compounded tirzepatide injection at any dose tier? PlexusDx Tirzepatide Injection at $249/mo is below Eden's $329/mo across the full ladder. Question 4: Do you want a genetic baseline informing dose and titration before week one? PlexusDx is the only option in this comparison that bundles a $99 add-on Precision Peptide Genetic Test with the protocol pathway. If your insurance covers Wegovy or Zepbound at a low copay, none of these compounded routes is the cheapest path; manufacturer self-pay or covered branded is.

Frequently asked questions

How does Eden's GLP-1 cost compare to PlexusDx's published pricing?

Eden's compounded semaglutide annualizes to $2,428–$2,668/year and compounded tirzepatide to $3,868/year. PlexusDx Semaglutide Injection annualizes to $2,148–$2,748/year and Tirzepatide Injection to $2,748–$3,708/year. At the entry tiers, PlexusDx is meaningfully cheaper on both compounds; at the maintenance tiers the two are roughly comparable on semaglutide and PlexusDx remains below Eden on tirzepatide.

Does PlexusDx have a flat-priced GLP-1 like Eden's $249/mo plan?

Yes. The PlexusDx Microdose GLP-1 Protocol is $129/mo flat — lower than Eden's lowest published compounded price of $249/mo on the 3-month prepaid plan and $229/mo on the monthly plan. The Microdose protocol uses a compounded GLP-1 in capsule, troche, lozenge, or sublingual format, provider-selected.

Is PlexusDx cheaper than Eden for compounded tirzepatide?

Yes, across the full dose ladder. Eden's compounded tirzepatide is $329/mo. PlexusDx Tirzepatide Injection is $249/mo across six dose levels. Annualized, PlexusDx Tirzepatide Injection saves $160–$1,120/year versus Eden's compounded tirzepatide.

Does PlexusDx accept insurance, HSA, or FSA?

PlexusDx is cash-pay only and does not bill commercial insurance, Medicare, or Medicaid. HSA and FSA cards may be accepted subject to IRS rules, which require a physician-diagnosed qualifying condition for weight-loss medication to be reimbursable. Confirm eligibility with your plan administrator. PlexusDx has no membership fee.

Are PlexusDx's compounded GLP-1 medications FDA-approved?

No. Compounded semaglutide and tirzepatide are not FDA-approved finished drug products at PlexusDx, Eden, or any other compounding-pharmacy route. They are prepared by state-licensed compounding pharmacies under a clinician's prescription. Only branded finished products like Wegovy, Ozempic, Zepbound, and Mounjaro carry FDA approval. The boxed warning for thyroid C-cell tumors based on rodent studies applies to both semaglutide and tirzepatide regardless of source.

Is PlexusDx available in all 50 states like Eden?

Yes. PlexusDx Weight Management Protocols are available in all 50 states. Five states require a scheduled live consultation rather than async intake; the remaining 45 use async clinician review.

Does the Precision Peptide Genetic Test add a lot to my monthly cost?

No. The Precision Peptide Genetic Test is $99 as an add-on after your first month on any PlexusDx Weight Management Protocol, or $298 standalone. The $99 is a one-time fee, not a monthly subscription, and it covers 48 genes, 57 variants, 14 health pathways, and 34 weight-management insights including the GIPR rs1800437 variant tied to differential GLP-1 response.

Related reading on PlexusDx: GLP-1 Cost, Semaglutide Cost, Tirzepatide Costs, Cheapest GLP-1.

Disclaimer: This article is educational and is not medical advice. PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols. Pricing for Eden is based on Eden's published rates as of April 2026; actual costs may vary by state, plan, and individual eligibility. PlexusDx does not sell, prescribe, or recommend any therapeutic peptide outside the GLP-1 category covered by its protocols. Discuss any GLP-1 medication decision with a licensed clinician.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.